美国临床肿瘤学会会刊报道的前列腺癌和乳腺癌临床研究趋势

R. Chlebowski, M. Curti
{"title":"美国临床肿瘤学会会刊报道的前列腺癌和乳腺癌临床研究趋势","authors":"R. Chlebowski, M. Curti","doi":"10.1046/J.1525-1411.2001.31004.X","DOIUrl":null,"url":null,"abstract":"Objectives: To identify recent clinical research trends, all abstracts relevant to prostate and breast cancer reported in the American Society of Clinical Oncology (ASCO) Proceedings from 1994 to 1999 and for 1 year in the American Urological Association Proceedings were reviewed. Methods: Abstracts were identified and prospectively categorized in 31 areas including study design, sample size, and study outcome. Results: In the ASCO Proceedings, abstracts on breast cancer (n = 1718) greatly exceeded those on prostate cancer (n = 340). Randomized clinical trials were also more frequently reported in breast cancer compared to prostate cancer (176 versus 30 reports, respectively [5.7 times greater]; p 12 times as many patients (121,923 women versus 9,761 men, respectively; p < 0.01) in this period. For breast cancer, the number of reported randomized clinical trials increased and nearly doubled over the 6-year period, whereas for prostate cancer no such trend was seen. For prostate cancer, the vast majority (82%) of the 130 clinical trial reports were nonrandomized studies, and most entered very few patients (median patient entry, 26.2). Although randomized clinical trial reports on breast cancer described significant survival benefits in 16 trials in both advanced disease (benefit seen in 7 of 109 studies [6%]) and especially in adjuvant therapy (benefit seen in 9 of 67 studies [12%]), in prostate cancer only a single randomized clinical trial reported a significant survival benefit in this period. Conclusions: Despite comparable annual incidence and mortality, prostate cancer receives only a fraction of the clinical trial activity afforded breast cancer.","PeriodicalId":22947,"journal":{"name":"The open prostate cancer journal","volume":"25 1","pages":"26-29"},"PeriodicalIF":0.0000,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Trends in Prostate and Breast Cancer Clinical Research as Reported in the American Society of Clinical Oncology Proceedings\",\"authors\":\"R. Chlebowski, M. Curti\",\"doi\":\"10.1046/J.1525-1411.2001.31004.X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: To identify recent clinical research trends, all abstracts relevant to prostate and breast cancer reported in the American Society of Clinical Oncology (ASCO) Proceedings from 1994 to 1999 and for 1 year in the American Urological Association Proceedings were reviewed. Methods: Abstracts were identified and prospectively categorized in 31 areas including study design, sample size, and study outcome. Results: In the ASCO Proceedings, abstracts on breast cancer (n = 1718) greatly exceeded those on prostate cancer (n = 340). Randomized clinical trials were also more frequently reported in breast cancer compared to prostate cancer (176 versus 30 reports, respectively [5.7 times greater]; p 12 times as many patients (121,923 women versus 9,761 men, respectively; p < 0.01) in this period. For breast cancer, the number of reported randomized clinical trials increased and nearly doubled over the 6-year period, whereas for prostate cancer no such trend was seen. For prostate cancer, the vast majority (82%) of the 130 clinical trial reports were nonrandomized studies, and most entered very few patients (median patient entry, 26.2). Although randomized clinical trial reports on breast cancer described significant survival benefits in 16 trials in both advanced disease (benefit seen in 7 of 109 studies [6%]) and especially in adjuvant therapy (benefit seen in 9 of 67 studies [12%]), in prostate cancer only a single randomized clinical trial reported a significant survival benefit in this period. Conclusions: Despite comparable annual incidence and mortality, prostate cancer receives only a fraction of the clinical trial activity afforded breast cancer.\",\"PeriodicalId\":22947,\"journal\":{\"name\":\"The open prostate cancer journal\",\"volume\":\"25 1\",\"pages\":\"26-29\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2001-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The open prostate cancer journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1046/J.1525-1411.2001.31004.X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The open prostate cancer journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1046/J.1525-1411.2001.31004.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:回顾1994年至1999年美国临床肿瘤学会(ASCO)会刊和1年来美国泌尿外科学会会刊上发表的所有与前列腺癌和乳腺癌相关的摘要,以确定最近的临床研究趋势。方法:从31个方面对摘要进行识别和前瞻性分类,包括研究设计、样本量和研究结果。结果:在ASCO Proceedings中,关于乳腺癌的摘要(n = 1718)大大超过关于前列腺癌的摘要(n = 340)。与前列腺癌相比,随机临床试验在乳腺癌中的报道频率也更高(分别为176例对30例,[高出5.7倍];P为12倍(121923名女性vs 9761名男性);P < 0.01)。对于乳腺癌,报道的随机临床试验的数量增加了,在6年的时间里几乎翻了一番,而对于前列腺癌,没有这种趋势。对于前列腺癌,在130个临床试验报告中,绝大多数(82%)是非随机研究,大多数纳入的患者很少(中位患者入组26.2)。尽管在乳腺癌的随机临床试验报告中,有16项试验在晚期疾病(109项研究中的7项[6%])和特别是辅助治疗(67项研究中的9项[12%])中描述了显著的生存获益,但在前列腺癌中,只有一项随机临床试验在此期间报告了显著的生存获益。结论:尽管前列腺癌的年发病率和死亡率相当,但其临床试验活动仅为乳腺癌的一小部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Trends in Prostate and Breast Cancer Clinical Research as Reported in the American Society of Clinical Oncology Proceedings
Objectives: To identify recent clinical research trends, all abstracts relevant to prostate and breast cancer reported in the American Society of Clinical Oncology (ASCO) Proceedings from 1994 to 1999 and for 1 year in the American Urological Association Proceedings were reviewed. Methods: Abstracts were identified and prospectively categorized in 31 areas including study design, sample size, and study outcome. Results: In the ASCO Proceedings, abstracts on breast cancer (n = 1718) greatly exceeded those on prostate cancer (n = 340). Randomized clinical trials were also more frequently reported in breast cancer compared to prostate cancer (176 versus 30 reports, respectively [5.7 times greater]; p 12 times as many patients (121,923 women versus 9,761 men, respectively; p < 0.01) in this period. For breast cancer, the number of reported randomized clinical trials increased and nearly doubled over the 6-year period, whereas for prostate cancer no such trend was seen. For prostate cancer, the vast majority (82%) of the 130 clinical trial reports were nonrandomized studies, and most entered very few patients (median patient entry, 26.2). Although randomized clinical trial reports on breast cancer described significant survival benefits in 16 trials in both advanced disease (benefit seen in 7 of 109 studies [6%]) and especially in adjuvant therapy (benefit seen in 9 of 67 studies [12%]), in prostate cancer only a single randomized clinical trial reported a significant survival benefit in this period. Conclusions: Despite comparable annual incidence and mortality, prostate cancer receives only a fraction of the clinical trial activity afforded breast cancer.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
新規PET検査の進歩 (特集 前立腺がんのスクリーニングと診断) PVP : 効率的な蒸散のために (特集 前立腺肥大症手術のコツとトラブルシューティング) 強度変調放射線治療(IMRT) (特集 前立腺がんに対する放射線治療最前線) -- (放射線治療の新規技術による治療成績と適応拡大) 専門医試験に役立つ前立腺知識 日本泌尿器科学会専門医資格試験2013年度解説 : 前立腺癌関連 QOL,患者の満足度 (特集 前立腺がんの手術) -- (ロボット支援手術について)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1